ANALGESICS IN AUSTRALIA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Reverse Switch Has A Negative Impact on Sales of Analgesics

Alternative Analgesics for Mild Pain Likely To Fill the Gap Left by Codeine's Withdrawal

Ageing Population Set To Spur Growth in Analgesics

Competitive Landscape

Gsk Consumer Healthcare Continues To Lead in Analgesics

Companies Respond To the Ban on OTC Sales of Codeine

Panadol Bounces Back Despite Strong Competition From Generics

Category Data

Table 1 Sales of Analgesics by Category: Value 2013-2018

Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018

Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018

Table 4 NBO Company Shares of Analgesics: % Value 2014-2018

Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018

Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Executive Summary

Regulation and Shifting Demand for Vitamins and Dietary Supplement Define Industry

Consumer Health Products Remain Popular in Australia But Sales Slow Down

Acquisitions of Local Companies Continue

Distribution Continues To Evolve As the Presence of Discount Pharmacies Increases

the Trend Towards Self-care Management Set To Support Consumer Health Sales

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Definitions

Sources

Summary 2 Research Sources

Increasing concerns in Australia about the addictive nature of codeine resulted in the rescheduling of all codeine-containing OTC medicines to prescription-only status in February 2018. This ban on OTC sales of codeine had a significant impact on sales of analgesics during 2018, particularly on combination medicines. Value sales of codeine-containing analgesics had already begun to decline in 2017 because of the more limited availability of these products following the imposition of restrictions...

Euromonitor International's Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.